399 related articles for article (PubMed ID: 29570265)
1. Integrated Analysis of Exosomal Protein Biomarkers on Alternating Current Electrokinetic Chips Enables Rapid Detection of Pancreatic Cancer in Patient Blood.
Lewis JM; Vyas AD; Qiu Y; Messer KS; White R; Heller MJ
ACS Nano; 2018 Apr; 12(4):3311-3320. PubMed ID: 29570265
[TBL] [Abstract][Full Text] [Related]
2. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
[TBL] [Abstract][Full Text] [Related]
3. Rapid Isolation and Detection of Exosomes and Associated Biomarkers from Plasma.
Ibsen SD; Wright J; Lewis JM; Kim S; Ko SY; Ong J; Manouchehri S; Vyas A; Akers J; Chen CC; Carter BS; Esener SC; Heller MJ
ACS Nano; 2017 Jul; 11(7):6641-6651. PubMed ID: 28671449
[TBL] [Abstract][Full Text] [Related]
4. Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies.
Sharma R; Huang X; Brekken RA; Schroit AJ
Br J Cancer; 2017 Aug; 117(4):545-552. PubMed ID: 28641308
[TBL] [Abstract][Full Text] [Related]
5. miRNA Profiling of Magnetic Nanopore-Isolated Extracellular Vesicles for the Diagnosis of Pancreatic Cancer.
Ko J; Bhagwat N; Black T; Yee SS; Na YJ; Fisher S; Kim J; Carpenter EL; Stanger BZ; Issadore D
Cancer Res; 2018 Jul; 78(13):3688-3697. PubMed ID: 29735554
[TBL] [Abstract][Full Text] [Related]
6. Detection of exosomal biomarker by electric field-induced release and measurement (EFIRM).
Tu M; Wei F; Yang J; Wong D
J Vis Exp; 2015 Jan; (95):52439. PubMed ID: 25650727
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes.
Kanwar SS; Dunlay CJ; Simeone DM; Nagrath S
Lab Chip; 2014 Jun; 14(11):1891-900. PubMed ID: 24722878
[TBL] [Abstract][Full Text] [Related]
8. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.
Madhavan B; Yue S; Galli U; Rana S; Gross W; Müller M; Giese NA; Kalthoff H; Becker T; Büchler MW; Zöller M
Int J Cancer; 2015 Jun; 136(11):2616-27. PubMed ID: 25388097
[TBL] [Abstract][Full Text] [Related]
9. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches.
Zarovni N; Corrado A; Guazzi P; Zocco D; Lari E; Radano G; Muhhina J; Fondelli C; Gavrilova J; Chiesi A
Methods; 2015 Oct; 87():46-58. PubMed ID: 26044649
[TBL] [Abstract][Full Text] [Related]
10. High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery.
Buscail E; Alix-Panabières C; Quincy P; Cauvin T; Chauvet A; Degrandi O; Caumont C; Verdon S; Lamrissi I; Moranvillier I; Buscail C; Marty M; Laurent C; Vendrely V; Moreau-Gaudry F; Bedel A; Dabernat S; Chiche L
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31717747
[TBL] [Abstract][Full Text] [Related]
11. Combined Exosomal GPC1, CD82, and Serum CA19-9 as Multiplex Targets: A Specific, Sensitive, and Reproducible Detection Panel for the Diagnosis of Pancreatic Cancer.
Xiao D; Dong Z; Zhen L; Xia G; Huang X; Wang T; Guo H; Yang B; Xu C; Wu W; Zhao X; Xu H
Mol Cancer Res; 2020 Feb; 18(2):300-310. PubMed ID: 31662449
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy.
Yang KS; Im H; Hong S; Pergolini I; Del Castillo AF; Wang R; Clardy S; Huang CH; Pille C; Ferrone S; Yang R; Castro CM; Lee H; Del Castillo CF; Weissleder R
Sci Transl Med; 2017 May; 9(391):. PubMed ID: 28539469
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer.
Li Z; Tao Y; Wang X; Jiang P; Li J; Peng M; Zhang X; Chen K; Liu H; Zhen P; Zhu J; Liu X; Liu X
Cell Physiol Biochem; 2018; 51(2):610-629. PubMed ID: 30458449
[TBL] [Abstract][Full Text] [Related]
14. Development of serum parameters panels for the early detection of pancreatic cancer.
Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
[TBL] [Abstract][Full Text] [Related]
15. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
16. Progress and potential of exosome analysis for early pancreatic cancer detection.
Erb U; Zöller M
Expert Rev Mol Diagn; 2016 Jul; 16(7):757-67. PubMed ID: 27206554
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K
J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
[TBL] [Abstract][Full Text] [Related]
18. Integrated microfluidic-SERS for exosome biomarker profiling and osteosarcoma diagnosis.
Han Z; Peng X; Yang Y; Yi J; Zhao D; Bao Q; Long S; Yu SX; Xu XX; Liu B; Liu YJ; Shen Y; Qiao L
Biosens Bioelectron; 2022 Dec; 217():114709. PubMed ID: 36115123
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.
Tao L; Zhou J; Yuan C; Zhang L; Li D; Si D; Xiu D; Zhong L
Metabolomics; 2019 May; 15(6):86. PubMed ID: 31147790
[TBL] [Abstract][Full Text] [Related]
20. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
LaConti JJ; Laiakis EC; Mays AD; Peran I; Kim SE; Shay JW; Riegel AT; Fornace AJ; Wellstein A
BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S1. PubMed ID: 25923219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
